Ipilimumab and Nivolumab Combination Therapy: A Randomized Study of an Immediate versus Delayed Exercise Intervention with FuNctional Capacity and Quality of Life Evaluations in Subjects with Advanced
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Bristol-Myers Squibb Company
Start Date
July 30, 2018
End Date
June 30, 2020
Administered By
Duke Cancer Institute
Awarded By
Bristol-Myers Squibb Company
Start Date
July 30, 2018
End Date
June 30, 2020